CPT 83020Laboratory

Hemoglobin electrophoresis

CPT 83020 is the billing code for hemoglobin electrophoresis, a laboratory test that separates and identifies different types of hemoglobin in the blood to diagnose blood disorders like sickle cell disease and thalassemia.

Showing rates for

National Average

Base Medicare rate

$17.14

This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.

RVU breakdown

Work RVU

0.37

PE RVU (NF)

0.15

MP RVU

0.01

Total RVU

0.53

Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High

NCCI bundling edits

Loading bundling edits…

Billing tips

Bill 83020 only once per specimen regardless of how many hemoglobin variants are identified, as the code covers complete electrophoretic analysis
Impact: Prevents duplicate billing denials and recoupment; ensures compliance with unit of service rules
Verify ICD-10 code supports medical necessity (D57.x for sickle cell, D56.x for thalassemia, Z13.0 for screening, R71.8 for abnormal blood findings)
Impact: Improves first-pass claim acceptance rate by 30-40%; prevents medical necessity denials requiring appeals
Do not bill 83020 with 83021 (hemoglobin chromatography) for the same specimen as they are considered alternative methods for the same analysis
Impact: Prevents bundling denials and potential audit flags for unbundling; only one method should be billed per specimen
Document the specific clinical indication beyond routine screening for adult patients, as some payers require demonstrated clinical suspicion
Impact: Reduces denial rate from 25% to under 5% for non-newborn screening cases; strengthens appeal position
For newborn screening, use appropriate screening diagnosis codes rather than disease codes to avoid claim edits and ensure proper reimbursement
Impact: Ensures payment under preventive screening benefits which may have different cost-sharing than diagnostic testing
When billing to state Medicaid programs, verify if 83020 is covered under state newborn screening programs which may have separate billing protocols
Impact: Some states reimburse through public health programs rather than Medicaid fee-for-service; prevents $17.14 write-offs

Live Field Datano reports yet

Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.

Working with CPT 83020?

Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.

Help build the field knowledge

MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.

Related actions

Frequently asked questions

What is the Medicare reimbursement rate for CPT 83020 in 2025?

The 2025 Medicare national average payment rate for CPT 83020 is $17.14 for both facility and non-facility settings. This rate is based on a total RVU of 0.53 multiplied by the 2025 conversion factor of 32.3465. Actual payment may vary by geographic location based on locality adjustments.

How often can you bill CPT 83020 for the same patient?

There is no specific Medicare frequency limitation for 83020, but medical necessity must be documented for repeat testing. Typically, initial diagnosis requires one test, and repeat testing is medically appropriate only when monitoring treatment response, evaluating pregnancy, assessing transfusion effects, or when clinical status changes. Most payers question repeat testing within 12 months without documented clinical indication.

What is the difference between CPT 83020 and 83021?

CPT 83020 is for hemoglobin electrophoresis, which uses electrical current to separate hemoglobin variants, while 83021 is for hemoglobin chromatography (HPLC), which uses column-based separation. Both accomplish the same diagnostic goal of identifying hemoglobin variants, and only one method should be billed per specimen. They are considered alternative techniques and should not be billed together for the same specimen.

Does CPT 83020 require prior authorization from Medicare or commercial payers?

Medicare does not typically require prior authorization for 83020, but medical necessity must be supported by appropriate diagnosis codes. Some Medicare Advantage plans and commercial payers may require prior authorization for non-newborn screening cases or when ordering multiple hemoglobin tests. Always verify payer-specific requirements, particularly for repeat testing or adult screening in low-risk populations.

What diagnosis codes support medical necessity for CPT 83020?

Common supporting diagnosis codes include D57.x (sickle-cell disorders), D56.x (thalassemia), Z13.0 (screening for hemoglobinopathies), R71.8 (other abnormality of red blood cells), D64.89 (other specified anemias), Z31.430-Z31.438 (preconception counseling), and O99.11x (anemia complicating pregnancy). Family history codes Z83.2 and ethnic risk factors also support screening indications.

Can CPT 83020 be billed for newborn screening?

Yes, 83020 can be billed for newborn hemoglobinopathy screening, typically with diagnosis code Z13.0. However, many states include newborn screening in state public health programs with separate reimbursement mechanisms outside of standard insurance billing. Verify whether your state manages newborn screening through public health funding or allows standard billing to Medicaid/commercial insurance.

What are the RVU values for CPT code 83020 in 2025?

For 2025, CPT 83020 has a Work RVU of 0.37, Practice Expense RVU of 0.15 (both facility and non-facility), and Malpractice RVU of 0.01, for a total RVU of 0.53. When multiplied by the 2025 conversion factor of 32.3465, this yields the Medicare payment rate of $17.14. These values are published in the CMS Physician Fee Schedule RVU25A released December 23, 2024.